Related Experiment Video
Updated: May 27, 2025

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
Development of a Claims-Based Computable Phenotype for Ulcerative Colitis Flares.
Daniel Copeland1, Jayson S Marwaha1,2, Daniel Wong1
1Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA.
Identifying acute severe ulcerative colitis (ASUC) admissions is challenging due to a lack of unique codes. A machine learning model accurately identifies ASUC cases from claims data, enabling research into this condition.
Area of Science:
- Gastroenterology
- Medical Informatics
- Machine Learning
Background:
- Acute severe ulcerative colitis (ASUC) lacks a unique diagnostic code, hindering research and tracking.
- Current methods cannot automatically identify ASUC hospital admissions from observational data.
Purpose of the Study:
- To develop an automated method for identifying hospital admissions for ASUC.
- To enable large-scale research on non-coded conditions like ASUC.
Main Methods:
- Retrospective cohort study of ulcerative colitis (UC) patients (2014-2019).
- Trained logistic regression, random forest (RF), and support vector machine (SVM) models on administrative claims data.
- Validated model performance using chart review data.
Main Results:
- The RF model achieved 95.5% classification accuracy and an AUROC of 0.96.
- Key predictive features included endoscopy findings, length of stay, age, and abdominal X-ray.
- The model demonstrated 81.5% sensitivity and 96.5% specificity for ASUC identification.
Conclusions:
- A machine learning model can reliably identify ASUC admissions from claims data.
- This automated approach facilitates the creation of large, accurate datasets for ASUC research.
- Improved identification of non-coded conditions can advance understanding and research in real-world data.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

